Live feed
Filing
SC 13G
SC 13G0000935836-24-000745·CRESCENT BIOPHARMA, INC.
Schedule 13G ownership disclosure
GLYCOMIMETICS INC
Security class unavailable · CUSIP: 38000Q102
Event date: 2024-11-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,000,000
- Percent of class
- 7.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-24-000745
- Form type
- SC 13G
- Filer
- CRESCENT BIOPHARMA, INC.
- CIK
- CIK 1253689
- Filed
- Nov 27, 2024
- Reporting period
- Nov 25, 2024
- Description
- Schedule 13G beneficial ownership